Delivery Order SPE2DB25D2204-SPE2DB25FTHBY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Infanrix DTAP Syringe 0.5ML, a pediatric vaccine product, with a contract value of $1,391.22. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INFANRIX DTAP Syringe 0.5mL, a pediatric diphtheria, tetanus, and acellular pertussis vaccine. This firm fixed-price delivery order, valued at $3,091.60, represents a small-value pharmaceutical procurement supporting military and federal healthcare systems. The award is non-competitive and utilizes no set-aside designation, indicating fulfillment through an existing contract...
- The Defense Logistics Agency awarded a $3,991.50 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 25, 2025, with ultimate completion scheduled for August 26, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract specifies performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,228.08 firm fixed-price delivery order by the Defense Logistics Agency on September 25, 2025, for INFANRIX DTAP Syringe 0.5ML, with an ultimate completion date of September 26, 2025. This award was not designated as a set-aside contract and was competitively awarded. The delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,174.44 and a performance period ending on June 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a $2,064.30 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The delivery order has an ultimate completion date of August 2, 2024 and is a firm-fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The fixed-price, firm-fixed-price contract has a ceiling value of $1,082.06 and a period of performance through March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) with a contract ceiling value of $7,909.80. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 11, 2025, with a ceiling value of $22,083.83. This firm fixed-price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The contract is unclassified as a set-aside and will be performed at the vendor's corporate office location in...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTHBYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Infanrix DTAP syringes (0.5 mL) with a ceiling value of $7,231.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for ultimate completion by September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen holds substantial contract authority within the Defense Health Agency and military healthcare supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and medical devices. The company's federal contract portfolio demonstrates consistent performance in fulfilling medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/25/25 |